Sprycel
Sprycel is a oncology medication containing Dasatinib, available as 50mg bottles.
Details
- Conditions
- Chronic myeloid leukaemia · Acute lymphoblastic leukaemia
- Therapeutic Class
- Tyrosine Kinase Inhibitor
- Pharmacological Class
- BCR-ABL Kinase Inhibitor
- Minor Side Effects
- diarrhoea, nausea, headache, fatigue
- Moderate Side Effects
- pleural effusion, haemorrhage, anaemia
- Dosage Forms
- Film-coated tablet
- Administration Route
- Oral use
- Prescription Status
- Prescription medicine
- Originator
- Bristol-Myers Squibb
- Onset Time
- variable
- Duration
- continuous
- Storage Instructions
- Store at room temperature in original packaging.
- Drug Interactions
- proton pump inhibitors, h2 antagonists
- Age Restrictions
- Not recommended for children under 1 year.
What you will receive
Sprycel is the originator brand name, made by Bristol-Myers Squibb. We use it here to identify the medicine only; we are not affiliated with Bristol-Myers Squibb and do not ship the original Sprycel.
- You receive a generic equivalent: the same active ingredient (Dasatinib) at the same dose, mostly recognised Indian branded generics from vetted manufacturers.
- The exact brand supplied depends on what is in stock at the dispatching warehouse.
- A regulated generic matches the original ingredient for ingredient by legal standard.